Immune-mediated meibomian gland dysfunction and dry eye disease related to trastuzumab emtansine chemotherapy in HER2 breast cancer: A case report

One of the most commonly administered drugs for human epidermal growth factor receptor 2 (HER2) breast cancer is trastuzumab emtansine (TDM-1). Unfortunately, this drug causes ocular surface disease as an adverse effect. This case report describes the diagnosis and management of meibomian gland dysf...

Cijeli opis

Bibliografski detalji

Glavni autori:	Andi Marsa Nadhira, Rina La Distia Nora, Anna Mira Lubis, Yulia Aziza
Format:	Artigo
Jezik:	Inglês
Izdano:	Wolters Kluwer Medknow Publications 2024-11-01
Serija:	Indian Journal of Ophthalmology. Case Reports
Teme:	dry eye disease her2 breast cancer meibomian gland dysfunction trastuzumab emtansine
Online pristup:	https://journals.lww.com/10.4103/IJO.IJO_269_24
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!